IFITM2 and Autoimmunity: Furthermore, increased expression of IFITM2 (an interferon-induced protein with pro-inflammatory antiviral properties) suggests reduced regulatory capacity; for example, increased IFITM2 expression in circulating CD4+ Treg cells has been associated with checkpoint-inhibitor induced autoimmunity in patients with melanoma13.